Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,149.00    10.00 (0.88%)
Bid:
1,148.50
Ask:
1,149.50
Spread: 1.00 (0.087%)
Market Cap: £9.75b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

14 Aug 2015 10:54

RNS Number : 0994W
Smith & Nephew Plc
14 August 2015
 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS

 

SMITH & NEPHEW PLC

 

14 August 2015

 

Smith & Nephew plc announces that the following transactions took place yesterday:

 

 

 Name

 

Role

Number of Ordinary Shares / ADS' purchased

Total shareholding following notification

Roberto Quarta

Chairman

4,629 Ordinary Shares

19,765 Ordinary Shares

Vinita Bali

Non-Executive Director

93 ADS'

1,293 ADS'

Ian Barlow

Non-Executive Director

153 Ordinary Shares

18,556 Ordinary Shares

The Rt Hon Baroness Bottomley of Nettlestone DL

Non-Executive Director

159 Ordinary Shares

18,215 Ordinary Shares

Erik Engstrom

Non-Executive Director

140 Ordinary Shares

15,140 Ordinary Shares

Michael Friedman

Non-Executive Director

96 ADS'

9,014 Ordinary Shares (including 4,258.5 ADS')

Brian Larcombe

Non-Executive Director

140 Ordinary Shares

40,508 Ordinary Shares

Joseph Papa

Non-Executive Director

96 ADS'

13,194 Ordinary Shares (including 6,346 ADS')

 

Notes:

 

1. The market value of Ordinary Shares purchased on 13 August 2015 was £11.88 per Ordinary Share.

 

2. The market value of ADS' purchased on 13 August 2015 was US$36.95 per ADS.

 

3. These shares were purchased for the Chairman and Non-Executive Directors in lieu of part of their annual fees.

 

4. The Ordinary Shares were purchased in London, UK and the ADS' were purchased in New York, US.

 

5. One ADS is the equivalent of two Ordinary Shares of US$0.20 each.

 

6. The percentages of issued share capital acquired, disposed and held following notification are all under 0.01% of the total issued share capital of the Company.

 

This announcement is made in accordance with the requirements of DTR 3.1.4 R (1)(a)

 

Vickie Grady

Deputy Company Secretary

Smith & Nephew plc

 

Tel: 020 7401 7646

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLIFEATVISLIE
Date   Source Headline
5th Jun 202612:12 pmRNSTransaction in Own Shares
4th Jun 20264:05 pmRNSDirector/PDMR Shareholding
3rd Jun 202611:21 amRNSDirector/PDMR Shareholding
3rd Jun 202610:35 amRNSAdmission to Trading
1st Jun 20263:10 pmRNSTotal Voting Rights
29th May 202610:37 amRNSTransaction in Own Shares
27th May 20269:31 amRNSPre Stabilisation Notice
22nd May 20261:32 pmRNSAdmission to Trading
22nd May 20269:58 amRNSTransaction in Own Shares
20th May 202611:25 amRNSDirector/PDMR Shareholding
19th May 20268:53 amRNSHolding(s) in Company
15th May 202612:28 pmRNSTransaction in Own Shares Replacement
15th May 202611:41 amRNSTransaction in Own Shares
14th May 20269:25 amRNSHolding(s) in Company
12th May 20264:03 pmRNSSterling Amount of Dividend
8th May 20267:00 amRNSShare Buyback Programme
6th May 20262:25 pmRNSResult of AGM
6th May 20267:00 amRNSSmith+Nephew First Quarter 2026 Trading Update
1st May 20261:10 pmRNSTotal Voting Rights
27th Apr 20267:00 amRNSExpert surgeons insights event for investors
22nd Apr 20268:46 amRNSNotice of Results
16th Apr 202611:12 amRNSDirector/PDMR Shareholding
15th Apr 20263:46 pmRNSDirector Declaration
14th Apr 20262:59 pmRNSReplacement: Annual Financial Report & AGM Notice
1st Apr 202612:23 pmRNSTotal Voting Rights
24th Mar 20264:16 pmRNSDirector/PDMR Shareholding
24th Mar 20268:45 amRNSHolding(s) in Company
16th Mar 20263:08 pmRNSAnnual Financial Report & Notice of AGM
16th Mar 20263:08 pmRNSAnnual Financial Report & Notice of AGM
10th Mar 20262:30 pmRNS-RSmith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury prevention
5th Mar 20267:30 amRNSDirector Declaration
2nd Mar 20261:36 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSFinal Results
5th Feb 202611:56 amRNSNotice of Results
2nd Feb 20264:00 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Feb 20263:05 pmRNSTotal Voting Rights
23rd Jan 20262:00 pmRNSDirector/PDMR Shareholding
21st Jan 20264:11 pmRNSCompletion of Acquisition
12th Jan 20264:30 pmRNSAcquisition of Integrity Orthopaedics
2nd Jan 202610:07 amRNSTotal Voting Rights
8th Dec 20257:00 amRNSNew Strategy and 2028 Financial Targets
1st Dec 20254:10 pmRNSTotal Voting Rights
19th Nov 202510:00 amRNSDirector/PDMR Shareholding
18th Nov 202510:18 amRNSHolding(s) in Company
12th Nov 20259:24 amRNSDirector/PDMR Shareholding
11th Nov 20254:40 pmRNSHolding(s) in Company
10th Nov 20251:46 pmRNSDirector/PDMR Shareholding
7th Nov 20259:38 amRNSDirector/PDMR Shareholding
7th Nov 20259:35 amRNSDirector/PDMR Shareholding
6th Nov 20257:01 amRNSDirectorate change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.